Katalog der Deutschen Nationalbibliothek

Neuigkeiten Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
 
 
 


Ergebnis der Suche nach: "000000000"
im Bestand: Gesamter Bestand

531 - 540 von 647
<< < > >>


Artikel 531 RVX 208
Enthalten in Drugs in R & D Bd. 11, 27.11.2012, Nr. 2, date:6.2011: 207-213
Online Ressource
Artikel 532 Safety and Efficacy of Buprenorphine/Naloxone in Opioid-Dependent Patients
Enthalten in Clinical drug investigation Bd. 30, 17.9.2012, Nr. 1, date:4.2010: 21-26
Online Ressource
Artikel 533 Safety and Efficacy of Topical Diclofenac Sodium Gel for Knee Osteoarthritis in Elderly and Younger Patients
Enthalten in Drugs & aging Bd. 28, 31.8.2012, Nr. 1, date:1.2011: 27-40
Online Ressource
Artikel 534 Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis
Enthalten in Clinical drug investigation Bd. 30, 28.8.2012, Nr. 6, date:6.2010: 351-364
Online Ressource
Artikel 535 Safety and Tolerability of an SQ-Standardized GRAss ALlergy Immunotherapy Tablet (GRAZAX®) in a Real-Life Setting for Three Consecutive Seasons — The GRAAL Trial
Enthalten in Clinical drug investigation Bd. 32, 13.12.2012, Nr. 7, date:7.2012: 451-463
Online Ressource
Artikel 536 Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Conjunctivitis
Enthalten in Clinical drug investigation Bd. 30, 24.8.2012, Nr. 10, date:10.2010: 675-685
Online Ressource
Artikel 537 Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler® in Japanese Patients with Asthma
Enthalten in Clinical drug investigation Bd. 32, 29.8.2012, Nr. 1, date:1.2012: 51-61
Online Ressource
Artikel 538 Safety and Tolerability of Loteprednol Etabonate 0.5% and Tobramycin 0.3% Ophthalmic Suspension in Pediatric Subjects
Enthalten in Pediatric drugs Bd. 14, 31.8.2012, Nr. 2, date:4.2012: 119-130
Online Ressource
Artikel 539 Safety and Tolerability of the Switch from Buprenorphine to Buprenorphine/Naloxone in an Italian Addiction Treatment Centre
Enthalten in Clinical drug investigation Bd. 30, 17.9.2012, Nr. 1, date:4.2010: 27-31
Online Ressource
Artikel 540 Safety-Related Regulatory Actions for Orphan Drugs in the US and EU
Enthalten in Drug safety Bd. 33, 19.10.2012, Nr. 2, date:2.2010: 127-137
Online Ressource


531 - 540 von 647
<< < > >>


E-Mail-IconAdministration